Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.
about
Long term hormone therapy for perimenopausal and postmenopausal womenMolecular cancer prevention: Current status and future directionsSex- and gender-specific disparities in colorectal cancer riskHow significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?Intestinal tumorigenesis is not affected by progesterone signaling in rodent modelsLong-term hormone therapy for perimenopausal and postmenopausal women.Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort.Hormone therapy, DNA methylation and colon cancer.Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.Primary prevention of colorectal cancer.Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women.Increased risk of colon cancer in men in the pre-diabetes phase.Reproductive history and risk of colorectal cancer in postmenopausal womenUse of electronic medical records in oncology outcomes researchPrevention of colorectal cancer and dietary managementReproductive and hormonal factors and mortality among women with colorectal cancer in the NIH-AARP Diet and Health Study.Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.Estrogen plus progestin and colorectal cancer incidence and mortalityGender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort studyDiet Quality and Colorectal Cancer Risk in the Women's Health Initiative Observational StudyColorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational studyHormone therapy in relation to survival from large bowel cancer.Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends.The Effect of Sex on the Azoxymethane/Dextran Sulfate Sodium-treated Mice Model of Colon Cancer.Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.Colorectal cancer in women: hormone replacement therapy and chemoprevention.Oestrogen and colorectal cancer: mechanisms and controversies.Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.Bisphenol a exposure promotes the migration of NCM460 cells via estrogen receptor-mediated integrin β1/MMP-9 pathway.Estrogen and colorectal cancer incidence and mortality.Sex hormones and colorectal cancer: what have we learned so far?Risk factors for colon cancer in 150,912 postmenopausal women.Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
P2860
Q24201974-1F357C6D-A190-47D1-870B-89239710EDBAQ26797207-10595236-A77A-4D77-9B7E-7C71B4721F22Q27008466-8417D4D6-EA92-4134-BDA3-DA3A6232CCD9Q28067170-A0FD8054-5E0C-4095-AFDE-6D61E371CBA2Q28742085-09139077-D734-4E73-8E5C-59CF67528596Q30238978-5E1D8FA6-11F5-49B3-A552-A9FC6026B97BQ30537190-56BE54B7-67C2-4B51-BA3D-F75F87021B43Q30659580-217F42E3-20BC-470E-BDDC-A5464AC95EA2Q33589372-89F06F08-E355-4DEA-8256-6CD19E2C4786Q33718863-8C049FD5-C044-4F8C-A693-34E249E1604CQ33884570-7817313F-6F93-4DDC-82F9-1A14254AC062Q34145853-04233609-4B75-433F-8BF7-9078313591F9Q34165145-3F69835E-FBBB-4339-B71E-1C74F94A718EQ34315478-9799CE1F-6C7B-40DD-ACDC-01C1A7490417Q34324609-6983B4E6-4E10-4099-AAAF-230D3612A97DQ34420014-38153332-20C5-4182-880A-7B89A01A3EC1Q34621781-46D0255F-18A1-4708-87C8-AD6E533EB73CQ34925766-AF633306-CF37-443C-B673-CF7CDA7FCD84Q34988342-29E44F29-BDC5-4724-AD57-C04D70780E1CQ35205339-0C2970AA-F77A-4625-AB21-97DBD796A8A5Q35557470-A5A73CF9-3FE4-4A5E-9F38-73C12D53BD71Q35909636-0E1CFD07-7873-4F16-8966-5237A42026C9Q36306224-7802CDBD-BFB5-4654-B8EF-E907298162D5Q36368906-90FE4B2F-B1F6-4546-8137-990F0A49FCB4Q36418348-8354FD14-3504-45DA-9604-9E6949994144Q37056882-F1CDD5D5-2B83-4D09-864D-C8C0F4B6FC86Q37209821-6C1EFE44-4F90-4D3A-BC6C-ECACC2B0D693Q37309805-4C744832-58EC-4589-BB96-7814043920DCQ37321697-402E5959-1877-4433-86D1-823D6779C0E4Q37349131-BE4FF5EC-0A20-412D-8BE7-6833E9D88C83Q37552326-FEB9CB0C-DC40-4AEA-9253-292C9E0785D6Q37633453-AFD05E12-7081-49E5-8292-8BAEDC79CB48Q38011783-8AC814D3-D269-4C7D-BFDD-43582C7A6AF8Q38074097-0DFEC707-AE63-4161-95DD-E17D4BFEEB9AQ38106748-98C8291A-C842-4738-8995-399675EBC33BQ38926051-060B9C79-BF6B-411C-9F41-362B1116BC17Q41699978-94108350-6A32-4A57-8F65-0CD8364B1034Q42338932-555EE354-3922-49DC-AA99-9B055B72311DQ43537057-4D6631BA-ED6B-4539-9BCF-BBA6D81441E5Q43866332-C3967ED2-A540-4A2F-B696-DE47E9060CAA
P2860
Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Conjugated equine estrogens an ...... ive randomized clinical trial.
@ast
Conjugated equine estrogens an ...... ive randomized clinical trial.
@en
Conjugated equine estrogens an ...... ive randomized clinical trial.
@nl
type
label
Conjugated equine estrogens an ...... ive randomized clinical trial.
@ast
Conjugated equine estrogens an ...... ive randomized clinical trial.
@en
Conjugated equine estrogens an ...... ive randomized clinical trial.
@nl
prefLabel
Conjugated equine estrogens an ...... ive randomized clinical trial.
@ast
Conjugated equine estrogens an ...... ive randomized clinical trial.
@en
Conjugated equine estrogens an ...... ive randomized clinical trial.
@nl
P2093
P2860
P1476
Conjugated equine estrogens an ...... ive randomized clinical trial.
@en
P2093
Cedric Garland
Cheryl Ritenbaugh
Dorothy Lane
Ellen Mason
Gail Frank
James M Shikany
Janet L Stanford
LieLing Wu
Marcia L Stefanick
Robert E Schoen
P2860
P304
P356
10.1158/1055-9965.EPI-08-0385
P577
2008-09-30T00:00:00Z